-
SBI Healthcare Opportunities IDCW-R
Equity healthcare
Overview ( as on 08/01/26 )
NAV
₹267.95
Last change
₹-2.59 -0.01%
Fund Size (AUM)
3989.42 Cr
Performance
15.85% (5Y)
Fund Details
SBI Healthcare Opportunities IDCW-R
as of 08/01/26
AUM
3989.42 Cr
Expense Ratio
1.93 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01461
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities IDCW-R | -3.6% | 24.31% | 15.85% |
| BSE Healthcare TR INR | -3.26% | 23.89% | 15.1% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.64% |
Divi's Laboratories Ltd |
7.05% |
Max Healthcare Institute Ltd Ordinary Shares |
5.24% |
Lupin Ltd |
4.44% |
Laurus Labs Ltd |
3.89% |
Torrent Pharmaceuticals Ltd |
3.86% |
Acutaas Chemicals Ltd |
3.85% |
Cipla Ltd |
3.79% |
Biocon Ltd |
3.16% |
Jupiter Life Line Hospitals Ltd |
3.14% |
Sector Allocation
Healthcare |
92.89% |
Basic Materials |
7.11% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
16.76% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
16.1% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.33% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.33% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.33% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
15.85% (5Y)
-
